Reneo Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Reneo Pharmaceuticals Ownership

Who owns Reneo Pharmaceuticals?

.

Reneo Pharmaceuticals Business Overview

Where is Reneo Pharmaceuticals headquartered?

Reneo Pharmaceuticals is headquartered in Irvine, California.

What is Reneo Pharmaceuticals’ revenue?

Reneo Pharmaceuticals disclosed revenue of 83M USD for 2023 and 54M USD for 2022.

How many employees does Reneo Pharmaceuticals have?

Reneo Pharmaceuticals has 8 employees.

What sector is Reneo Pharmaceuticals in?

Reneo Pharmaceuticals is a life science company.

When was Reneo Pharmaceuticals founded?

Reneo Pharmaceuticals was founded in 2014.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Reneo Pharmaceuticals

Reneo Pharmaceuticals, Inc.

18575 Jamboree Road Suite 275-S,
Irvine, California 92612
United States,
(858) 283-0280
www.reneopharma.com

Reneo Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic mitochondrial diseases with significant unmet medical needs. Reneo is initially developing REN001 in three rare genetic diseases that typically present with myopathy and have a high unmet medical need: primary mitochondrial myopathies (PMM), long-chain fatty acid oxidation disorders (LC-FAOD), and glycogen storage disease type V (McArdle disease). Reneo Pharmaceuticals was formed in 2014 and is based in Irvine, California.


 Subscribe to unlock this and 208,602
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.